Marbofloxacin
Therapeutic Category:
Anti-Bacterial
Inhibits pyruvate–ferredoxin oxidoreductase (PFOR) enzyme-dependent
electron transfer in anaerobic pathogens
Primary Use:
Treatment of Giardia, Cryptosporidium, and helminths (off-label in vet use)
Protozoa, helminths, anaerobic bacteria
Target Species:
Pets (dogs and cats), equine, swine, chicken, field animals, milking animals
Status:
Commercial
Monograph:
IP, EP, BP
Regulatory Status:
DMF, CEP
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.